Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications

J Ren, NN Wu, S Wang, JR Sowers… - Physiological …, 2021 - journals.physiology.org
The prevalence of heart failure is on the rise and imposes a major health threat, in part, due
to the rapidly increased prevalence of overweight and obesity. To this point …

[HTML][HTML] Mitochondrial ROS formation in the pathogenesis of diabetic cardiomyopathy

N Kaludercic, F Di Lisa - Frontiers in Cardiovascular Medicine, 2020 - frontiersin.org
Diabetic cardiomyopathy is a result of diabetes-induced changes in the structure and
function of the heart. Hyperglycemia affects multiple pathways in the diabetic heart, but …

Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis

K Sinha, J Das, PB Pal, PC Sil - Archives of toxicology, 2013 - Springer
Oxidative stress basically defines a condition in which prooxidant–antioxidant balance in the
cell is disturbed; cellular biomolecules undergo severe oxidative damage, ultimately …

Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways

K Huynh, BC Bernardo, JR McMullen… - Pharmacology & …, 2014 - Elsevier
Cardiovascular disease is the primary cause of morbidity and mortality among the diabetic
population. Both experimental and clinical evidence suggest that diabetic subjects are …

Mechanisms for the transition from physiological to pathological cardiac hypertrophy

CJ Oldfield, TA Duhamel… - Canadian journal of …, 2020 - cdnsciencepub.com
The heart is capable of responding to stressful situations by increasing muscle mass, which
is broadly defined as cardiac hypertrophy. This phenomenon minimizes ventricular wall …

Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease

J Ren, L Pulakat, A Whaley-Connell… - Journal of molecular …, 2010 - Springer
The metabolic syndrome is a constellation of metabolic disorders including obesity,
hypertension, and insulin resistance, components which are risk factors for the development …

[HTML][HTML] Autophagy and mitophagy in diabetic cardiomyopathy

S Kobayashi, Q Liang - Biochimica et Biophysica Acta (BBA)-Molecular …, 2015 - Elsevier
Diabetic cardiomyopathy is a heart muscle-specific disease that increases the risk of heart
failure and mortality in diabetic patients independent of vascular pathology. Mitochondria …

[HTML][HTML] Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes

X Xu, S Kobayashi, K Chen, D Timm, P Volden… - Journal of Biological …, 2013 - ASBMB
Cardiac autophagy is inhibited in type 1 diabetes. However, it remains unknown if the
reduced autophagy contributes to the pathogenesis of diabetic cardiomyopathy. We …

FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative …

C Lin, Y Guo, Y Xia, C Li, X Xu, T Qi, F Zhang… - Journal of molecular and …, 2021 - Elsevier
Irisin, the cleaved form of the fibronectin type III domain containing 5 (FNDC5) protein, is
involved in metabolism and inflammation. Recent findings indicated that irisin participated in …

CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis

L Chen, Z Yin, X Qin, X Zhu, X Chen, G Ding… - Pharmacological …, 2022 - Elsevier
Type 2 diabetes mellitus (T2D) contributes to sustained inflammation and myopathic
changes in the heart although the precise interplay between the two remains largely …